middle.news
Imricor Raises A$60 Million to Accelerate US Launch and Clinical Trials
9:36am on Monday 4th of May, 2026 AEST
•
Healthcare
Read Story
Imricor Raises A$60 Million to Accelerate US Launch and Clinical Trials
9:36am on Monday 4th of May, 2026 AEST
Key Points
A$60 million placement at A$1.85 per share
Funds to launch NorthStar in US pediatric and adult markets
Advances regulatory approvals for full Electrophysiology platform
Supports clinical trials including VISABL-VT and Pulsed Field Ablation
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imricor Medical Systems (ASX:IMR)
OPEN ARTICLE